- Home
- SONN vs PXLW Comparison
SONN vs PXLW Comparison
Compare SONN & PXLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- PXLW
- Stock Information
- Founded
- SONN N/A
- PXLW 1997
- Country
- SONN United States
- PXLW United States
- Employees
- SONN N/A
- PXLW N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- PXLW Semiconductors
- Sector
- SONN Health Care
- PXLW Technology
- Exchange
- SONN Nasdaq
- PXLW Nasdaq
- Market Cap
- SONN 32.4M
- PXLW 36.1M
- IPO Year
- SONN N/A
- PXLW 2000
- Fundamental
- Price
- SONN $4.02
- PXLW $6.93
- Analyst Decision
- SONN Strong Buy
- PXLW Strong Buy
- Analyst Count
- SONN 1
- PXLW 3
- Target Price
- SONN $20.00
- PXLW $14.33
- AVG Volume (30 Days)
- SONN 773.9K
- PXLW 124.7K
- Earning Date
- SONN 12-16-2025
- PXLW 11-11-2025
- Dividend Yield
- SONN N/A
- PXLW N/A
- EPS Growth
- SONN N/A
- PXLW N/A
- EPS
- SONN N/A
- PXLW N/A
- Revenue
- SONN $1,000,000.00
- PXLW $33,205,000.00
- Revenue This Year
- SONN $5,376.22
- PXLW N/A
- Revenue Next Year
- SONN N/A
- PXLW $23.74
- P/E Ratio
- SONN N/A
- PXLW N/A
- Revenue Growth
- SONN 1689.52
- PXLW N/A
- 52 Week Low
- SONN $1.08
- PXLW $4.67
- 52 Week High
- SONN $19.30
- PXLW $15.42
- Technical
- Relative Strength Index (RSI)
- SONN 44.01
- PXLW 49.01
- Support Level
- SONN $3.95
- PXLW $5.60
- Resistance Level
- SONN $5.06
- PXLW $7.20
- Average True Range (ATR)
- SONN 0.87
- PXLW 0.46
- MACD
- SONN -0.08
- PXLW 0.24
- Stochastic Oscillator
- SONN 18.83
- PXLW 79.69
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About PXLW Pixelworks Inc.
Pixelworks Inc is a provider of visual processing semiconductor and software solutions that enable consistently high-quality and authentic viewing experiences in a wide variety of applications. The company defines its key target markets as Mobile (smartphone and tablet), Home and Enterprise (projectors, personal video recorders (PVR), and over-the-air (OTA) streaming devices), and Cinema (creation, remastering, and delivery of digital video content). The company operates in one segment: the design, development, marketing and sale of IC solutions for use in electronic display devices. The company generates its revenue from two broad product markets: the Mobile market and the Home and Enterprise market. The majority of the revenue is earned in Japan.